Open AccessExpression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
Author(s) -
Ziming He,
Jinbin Chen,
Juncheng Wang,
Li Xu,
Zhongguo Zhou,
Minshan Chen,
Yaojun Zhang,
Mingmin Shi
Publication year - 2020
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0000000000001698
Subject(s) - hbsag , hepatocellular carcinoma , medicine , hepatitis b virus , gastroenterology , immunohistochemistry , hepatitis b , ascites , hepatectomy , hepatology , tissue microarray , hepatitis , carcinoma , antigen , pathology , virus , immunology , resection , surgery
Hepatitis B surface antigen (HBsAg) is a detectable index after hepatitis B virus (HBV) infection, which is a risk factor of hepatocellular carcinoma (HCC). However, few studies have focused on the expression of HBsAg in HCC patients' liver tissues. This study aimed to explore the potential utility of using HBsAg protein expression in normal liver tissues as a prognostic factor for HCC patients who underwent liver resection.